15. Structural Characterization of Disulfide-Linked, p53-Derived Peptide Dimers
M. C. DiGiorno*, N. Vithanage*, C. G. Victorio, D. F. Kreitler, V. K. Outlaw, N. Sawyer. Submitted. Preprint available here.
*Authors contributed equally
14. SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability
N. Vithanage*, R. H. Apurba*, H. Enesi Ozomarisi, C. J. Bair, E. Sugg, V. K. Outlaw. Submitted.
*Authors contributed equally
13. A Synthetic Route to Highly Substituted 1-Aminonaphthalenes from Readily Available Benzaldehydes
H. Enesi Ozomarisi, K. T. Sharpe, V. K. Outlaw. J. Org. Chem. 2024, 89 (2), 1310–1314.
12. Trimer-to-monomer disruption mechanism for a potent, protease-resistant antagonist of tumor necrosis factor-α signaling
J. Niu, A. J. Cederstrand, G. A. Eddinger, B. Yin, J. W. Checco, C. A. Bingman, V. K. Outlaw, S. H. Gellman. J. Am. Chem. Soc. 2022, 144 (22), 9610–9617.
11. Molecular features of the measles virus viral fusion complex that favor infection and spread in the brain
C. Mathieu, F. T. Bovier, M. Ferren, N. A. P. Lieberman, C. Predella, A. Lalande, V. Peddu, M. J. Lin, A. Addetia, A. Patel, V. K. Outlaw, B. Corneo, N. V. Dorrello, T. Briese, D. Hardie, B. Horvat, A. Moscona, A. L. Greninger, M. Porotto. mBio. 2021, 12 (3), ee00799-21.
10. Engineering protease-resistant peptides to inhibit human parainfluenza viral respiratory infection
V. K. Outlaw*, R. W. Cheloha*, E. M. Jurgens*, F. T. Bovier, Y. Zhu, D. F. Kreitler, O. Harder, S. Niewiesk, M. Porotto, S. H. Gellman, A. Moscona. J. Am. Chem. Soc. 2021, 143 (15), 5958–5966.
*Authors contributed equally
**Selected for a JACS Spotlight
9. Inhibition of coronavirus entry in vitro and ex vivo by a lipid-conjugated peptide derived from the SARS-CoV-2 spike glycoprotein HRC domain
V. K. Outlaw*, F. T. Bovier*, M. C. Mears, M. N. Cajimat, Y. Zhu, M. J. Lin, A. Addetia, N. A. P. Lieberman , V. Peddu, X. Xie, P.-Y. Shi, A. L. Greninger, S. H. Gellman, D. A. Bente, A. Moscona, M. Porotto. mBio. 2020, 11:e01935-20.
*Authors contributed equally
**Selected as Editor’s Pick
***Highlighted in Badger Chemist News
8. Effects of single α-to-β residue replacements on recognition of an extended segment in a viral fusion protein
V. K. Outlaw, D. F. Kreitler, D. Stelitano, M. Porotto, A. Moscona, S. H. Gellman. ACS Infect. Dis. 2020, 6 (8), 2017–2022.
7. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor
V. K. Outlaw, J. T. Lemke, Y. Zhu, S. H. Gellman, M. Porotto, A. Moscona. J. Am. Chem. Soc. 2020, 142 (5), 2140–2144.
6. Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent
V. K. Outlaw, S. Bottom-Tanzer, D. F. Kreitler, S. H. Gellman, M. Porotto, A. Moscona. J. Am. Chem. Soc. 2019, 141 (32), 12648–12656.
5. Quenching of pH-Responsive Luminescence of a Benzoindolizine Sensor by an Ultrafast Hydrogen Shift
J. Zhou, V. K. Outlaw, C. A. Townsend, A. E. Bragg. Chem. Eur. J. 2016, 22 (43), 15212–15215.
4. Unusual Blue-Shifted Acid-Responsive Photoluminescence Behavior in 6-Amino-8-Cyanobenzo[1,2-B]Indolizines
V. K. Outlaw, J. Zhou, A. E. Bragg, C. A. Townsend. RSC Adv. 2016, 6 (66), 61249–61253.
3. One-Pot Synthesis of Highly Substituted N-Fused Heteroaromatic Bicycles From Azole Aldehydes
V. K. Outlaw, F. B. d'Andrea, C. A. Townsend. Org. Lett. 2015, 17 (8), 1822–1825.
2. A Practical Route to Substituted 7-Aminoindoles From Pyrrole-3-Carboxaldehydes
V. K. Outlaw, C. A. Townsend. Org. Lett. 2014, 16 (24), 6334–6337.
1. Design, Synthesis, and Evaluation of 4- and 5-Substituted o-(Octanesulfonamido)benzoic Acids as Inhibitors of Glycerol-3-Phosphate Acyltransferase
V. K. Outlaw, E. A. Wydysh, A. Vadlamudi, S. M. Medghalchi, C. A. Townsend. Med. Chem. Comm. 2014, 5 (6), 826–830.